Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

Y. J. Park, E. H. Koh, J. Kim, J. K. Roh, J. Chang, C. M. Ahn, H. Y. Sohn, W. Y. Lee, K. Kim, Chang-Ok Suh, G. E. Kim, J. J.K. Loh, B. S. Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)30-37
Number of pages8
JournalYonsei medical journal
Volume30
Issue number1
DOIs
Publication statusPublished - 1989 Jan 1

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Drug Evaluation
Small Cell Carcinoma
Small Cell Lung Carcinoma
Vincristine
Etoposide
Doxorubicin
Cyclophosphamide
Cisplatin
Lung Neoplasms
Radiotherapy
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Park, Y. J. ; Koh, E. H. ; Kim, J. ; Roh, J. K. ; Chang, J. ; Ahn, C. M. ; Sohn, H. Y. ; Lee, W. Y. ; Kim, K. ; Suh, Chang-Ok ; Kim, G. E. ; Loh, J. J.K. ; Kim, B. S. / Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer. In: Yonsei medical journal. 1989 ; Vol. 30, No. 1. pp. 30-37.
@article{f9ee66a889e44eb8aaf43a0976ccb1f6,
title = "Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer",
author = "Park, {Y. J.} and Koh, {E. H.} and J. Kim and Roh, {J. K.} and J. Chang and Ahn, {C. M.} and Sohn, {H. Y.} and Lee, {W. Y.} and K. Kim and Chang-Ok Suh and Kim, {G. E.} and Loh, {J. J.K.} and Kim, {B. S.}",
year = "1989",
month = "1",
day = "1",
doi = "10.3349/ymj.1989.30.1.30",
language = "English",
volume = "30",
pages = "30--37",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "1",

}

Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer. / Park, Y. J.; Koh, E. H.; Kim, J.; Roh, J. K.; Chang, J.; Ahn, C. M.; Sohn, H. Y.; Lee, W. Y.; Kim, K.; Suh, Chang-Ok; Kim, G. E.; Loh, J. J.K.; Kim, B. S.

In: Yonsei medical journal, Vol. 30, No. 1, 01.01.1989, p. 30-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

AU - Park, Y. J.

AU - Koh, E. H.

AU - Kim, J.

AU - Roh, J. K.

AU - Chang, J.

AU - Ahn, C. M.

AU - Sohn, H. Y.

AU - Lee, W. Y.

AU - Kim, K.

AU - Suh, Chang-Ok

AU - Kim, G. E.

AU - Loh, J. J.K.

AU - Kim, B. S.

PY - 1989/1/1

Y1 - 1989/1/1

UR - http://www.scopus.com/inward/record.url?scp=0024539937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024539937&partnerID=8YFLogxK

U2 - 10.3349/ymj.1989.30.1.30

DO - 10.3349/ymj.1989.30.1.30

M3 - Article

C2 - 2545051

AN - SCOPUS:0024539937

VL - 30

SP - 30

EP - 37

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 1

ER -